Coherus Oncology to Report Full Year and Fourth Quarter 2025 Financial Results on March 9, 2026 Life Science Investing
AbbVie Announces Positive Topline Results from Phase 3 AFFIRM Study Evaluating SKYRIZI® Subcutaneous Induction in Patients with Crohn's Disease Pharmaceutical Investing
Gilead Foundation Awards $12 Million to Empower Community Health Workers and Expand HIV Prevention Initiatives Across 14 States and the District of Columbia Life Science Investing
Monopar Expands Leadership Team with Appointment of Seasoned Biopharma Executive Susan Rodriguez as Chief Commercial and Strategy Officer Life Science Investing
HCW Biologics Regains Compliance with All Continued Listing Rules for Nasdaq Per Nasdaq Determination Letter Life Science Investing
Nautilus Biotechnology Appoints Proteomics Commercial Leader Amber Faust as Vice President of Sales Life Science Investing
EraNova Metals Reports Samples of up to 257 g/t Gold and 3,660 g/t Silver at Lakeview and Defines New Drill Target on the Ruby Creek Property Life Science Investing
Palvella Therapeutics Announces Closing of Upsized Public Offering of Common Stock and Exercise in Full of the Underwriters' Option to Purchase Additional Shares Life Science Investing
